These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

573 related items for PubMed ID: 18480011

  • 1. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
    Al-Mawali A, Gillis D, Hissaria P, Lewis I.
    Am J Clin Pathol; 2008 Jun; 129(6):934-45. PubMed ID: 18480011
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [Abstract] [Full Text] [Related]

  • 3. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
    Zelezníková T, Babusíková O.
    Neoplasma; 2006 Nov; 53(6):500-6. PubMed ID: 17167719
    [Abstract] [Full Text] [Related]

  • 4. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR, Wang H, Chang Y, Cheng YF, Fu JY, Zhang LP, Liu GL, Chen SS.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [Abstract] [Full Text] [Related]

  • 5. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O.
    Neoplasma; 2007 Jun; 54(6):471-7. PubMed ID: 17949229
    [Abstract] [Full Text] [Related]

  • 6. Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow.
    Kern W, Danhauser-Riedl S, Ratei R, Schnittger S, Schoch C, Kolb HJ, Ludwig WD, Hiddemann W, Haferlach T.
    Haematologica; 2003 Jun; 88(6):646-53. PubMed ID: 12801840
    [Abstract] [Full Text] [Related]

  • 7. The use of receiver operating characteristic analysis for detection of minimal residual disease using five-color multiparameter flow cytometry in acute myeloid leukemia identifies patients with high risk of relapse.
    Al-Mawali A, Gillis D, Lewis I.
    Cytometry B Clin Cytom; 2009 Mar; 76(2):91-101. PubMed ID: 18727068
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry.
    Zelezníková T, Babusíková O.
    Neoplasma; 2005 Mar; 52(6):517-22. PubMed ID: 16284699
    [Abstract] [Full Text] [Related]

  • 10. The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia.
    Al-Mawali A, Gillis D, Lewis I.
    Am J Clin Pathol; 2009 Jan; 131(1):16-26. PubMed ID: 19095561
    [Abstract] [Full Text] [Related]

  • 11. Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group.
    MRD-AML-BFM Study GroupDepartment of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany. langebrake.claudia@mh-hannover.de, Langebrake C, Creutzig U, Dworzak M, Hrusak O, Mejstrikova E, Griesinger F, Zimmermann M, Reinhardt D.
    J Clin Oncol; 2006 Aug 01; 24(22):3686-92. PubMed ID: 16877738
    [Abstract] [Full Text] [Related]

  • 12. [Detection of minimal residual disease in patients with acute myeloid leukemia].
    Gal'tseva IV, Savchenko VG, Kulikov SM, Parovichnikova EN, Miterev GIu, Maslova ER, Isaev VG.
    Ter Arkh; 2003 Aug 01; 75(7):8-14. PubMed ID: 12934474
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comprehensive flow cytometry phenotype in acute leukemia at diagnosis and at relapse.
    Li X, Du W, Liu W, Li X, Li H, Huang SA.
    APMIS; 2010 May 01; 118(5):353-9. PubMed ID: 20477810
    [Abstract] [Full Text] [Related]

  • 15. Phenotypic quantitative features of patients with acute myeloid leukemia.
    Pereira FG, Metze K, Costa FP, Lima CS, Lorand-Metze I.
    Neoplasma; 2006 May 01; 53(2):155-60. PubMed ID: 16575472
    [Abstract] [Full Text] [Related]

  • 16. Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia.
    Hämäläinen MM, Kairisto V, Juvonen V, Johansson J, Aurén J, Kohonen K, Remes K, Salmi TT, Helenius H, Pelliniemi TT.
    Eur J Haematol; 2008 Mar 01; 80(3):201-7. PubMed ID: 18081724
    [Abstract] [Full Text] [Related]

  • 17. [Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study].
    Reinhardt D, Langebrake C, Creutzig U, Vormoor J, Brune C, Thorwesten M, Ingiliz P, Hrusak O, Dworzak M, Griesinger F.
    Klin Padiatr; 2002 Mar 01; 214(4):179-87. PubMed ID: 12165899
    [Abstract] [Full Text] [Related]

  • 18. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
    Pálóczi K, Nahajevszky S, Jakab K, Regéczy N, Gopcsa L, László E, Földi J.
    Orv Hetil; 2000 Nov 12; 141(46):2487-92. PubMed ID: 11126681
    [Abstract] [Full Text] [Related]

  • 19. Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings.
    Voskova D, Schoch C, Schnittger S, Hiddemann W, Haferlach T, Kern W.
    Cytometry B Clin Cytom; 2004 Nov 12; 62(1):25-38. PubMed ID: 15468339
    [Abstract] [Full Text] [Related]

  • 20. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A, Adib M, Mokarian F, Tebianian M, Nassiri R.
    Med Sci Monit; 2003 Aug 12; 9(8):CR359-62. PubMed ID: 12942032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.